FDA Launches Project Orbis, Mulls Expansion Of ADFs And Touts Rare Disease Cures Accelerator

Pink Sheet reporters discuss the US FDA's launch of its Project Orbis collaboration, the agency's call for comments on the development of abuse-deterrent formulations for central nervous system stimulants and the new Rare Disease Cures Accelerator.